Discover the detailed record of transactions filed by Shukla Sanjay, Chief Executive Officer. Insider active across 2 companies, notably aTYR PHARMA INC. In total, 6 filings have been recorded. Total volume traded: €163k. The latest transaction was filed on 7 January 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Sanjay Shukla is the President and CEO of aTYR PHARMA INC. He is responsible for the strategic direction of the company, focusing on innovation in the pharmaceutical sector. His leadership is essential for achieving growth and profitability objectives.